Outcomes of a nine-month regimen for rifampicin-resistant tuberculosis up to 24 months after treatment completion in nine African countries

Treatment outcomes of the shorter regimen for rifampicin-resistant tuberculosis are not completely established. We report on these outcomes two years after treatment completion among patients enrolled in an observational cohort study in nine African countries. 1,006 patients treated with the nine-mo...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	EClinicalMedicine Jg. 20; S. 100268
Hauptverfasser:	Schwœbel, Valérie, Trébucq, Arnaud, Kashongwe, Zacharie, Bakayoko, Alimata S., Kuaban, Christopher, Noeske, Juergen, Harouna, Souleymane H., Souleymane, Mahamadou B., Piubello, Alberto, Ciza, François, Fikouma, Valentin, Gasana, Michel, Ouedraogo, Martial, Gninafon, Martin, Van Deun, Armand, Tagliani, Elisa, Cirillo, Daniela M., Koura, Kobto G., Rieder, Hans L.
Format:	Journal Article
Sprache:	Englisch
Veröffentlicht:	England Elsevier Ltd 01.03.2020 Elsevier
Schlagworte:	Cohort studies Developing countries Fluoroquinolones Internal Medicine Isoniazid Multidrug-resistance Proportional hazard models Recurrence Research paper Short regimen Treatment outcome Tuberculosis Fluoroquinolones Treatment outcome Recurrence Tuberculosis Short regimen Cohort studies Developing countries Proportional hazard models Isoniazid Multidrug-resistance
ISSN:	2589-5370, 2589-5370
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!